Such studies demonstrated that the peptide can interact with the protein kinase CK2α catalytic subunit and impair CK2 enzymatic activity in non-small cell lung cancer (NSCLC) and T-cell acute lymphoblastic leukemia (T-ALL) cell lines [33,34]. The gene discussed is WEE1; the disease is non-small cell lung carcinoma.